Heritage: Company Milestones

Timeline

1897

 

Marcel Mérieux creates the Institut Mérieux, which developed a large range of vaccines and biological products, including reagents. Alain Mérieux was president of the Institut for 25 years, until 1994

1963

 

Creation of bioMérieux

1986

 

API Systems (France) acquisition 

1988

 

Vitek acquisition from McDonnel Douglas (U.S.)

2001

 

Organon Teknika Diagnostic acquisition from Akzo Nobel (Netherlands)

2004

 

Listing of bioMérieux on the stock exchange

2006

 

Inauguration of the Christophe Mérieux Center, dedicated to molecular biology and microsystems research (Grenoble, France)

Bacterial Barcodes (U.S.) acquisition

2007

 

Biomedics (Spain) acquisition

BTF (Australia) acquisition

2008

 

Joint venture with Sysmex (Japan)

Joint venture with Shanghai Kehua Bio-engineering (China)

AB BIODISK (Sweden) acquisition

AviaraDx acquisition (U.S.) – renamed bioTheranostics

PML Microbiologicals Inc. acquisition (U.S.)

2009

 

Collaboration agreement with GlaxoSmithKline (United Kingdom)

Strategic partnership with the French Atomic Energy Commission (CEA)

2010

 

Collaboration agreement with Royal Philips Electronics (the Netherlands)

Acquisition of Meikang Biotech (China)

Acquisition of Shanghai Zenka Biotechnology (China)

Strategic agreements with Shimadzu (Japan) and AnagnosTec (Germany)

Strategic partnership with Biocartis (Switzerland)

Strategic partnership with Knome (U.S.)

Agreement with GlaxoSmithKline (United Kingdom)

2011

 

Partnership with Ipsen (France)

Acquisitions of AES Laboratoire and ARGENE (France)

2012

 

Acquisition of RAS (India)

2013

 

Acquisition of BioFire Diagnostics, Inc. (U.S.)

 

Pioneering diagnostics